Healthcare provider profile · identity verified

Pareed Aliyar, M.D.

Cardiology · LAKE HAVASU CITY, AZ · NPI 1780686832

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	515	154
Atorvastatin Calcium	Atorvastatin Calcium	432	135
Metoprolol Succinate	Metoprolol Succinate	420	126
Amlodipine Besylate	Amlodipine Besylate	390	121
Eliquis	Apixaban	380	105
Spironolactone	Spironolactone	277	89
Furosemide	Furosemide	270	83
Metoprolol Tartrate	Metoprolol Tartrate	232	72
Levothyroxine Sodium	Levothyroxine Sodium	225	65
Clopidogrel	Clopidogrel Bisulfate	222	75
Losartan Potassium	Losartan Potassium	206	68
Lisinopril	Lisinopril	204	64
Doxazosin Mesylate	Doxazosin Mesylate	198	55
Carvedilol	Carvedilol	184	53
Ezetimibe	Ezetimibe	184	57
Amiodarone Hcl	Amiodarone Hcl	168	68
Entresto	Sacubitril/Valsartan	157	40
Tamsulosin Hcl	Tamsulosin Hcl	153	49
Warfarin Sodium	Warfarin Sodium	130	42
Metformin Hcl	Metformin Hcl	125	45
Digoxin	Digoxin	111	32
Bisoprolol Fumarate	Bisoprolol Fumarate	107	32
Gabapentin	Gabapentin	104	32
Simvastatin	Simvastatin	99	29
Omeprazole	Omeprazole	97	33
Hydrochlorothiazide	Hydrochlorothiazide	95	30
Farxiga	Dapagliflozin Propanediol	93	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	89	32
Pantoprazole Sodium	Pantoprazole Sodium	85	31
Xarelto	Rivaroxaban	82	26
Trazodone Hcl	Trazodone Hcl	79	25
Atenolol	Atenolol	74	25
Sotalol	Sotalol Hcl	69	19
Ranolazine Er	Ranolazine	68	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	18
Escitalopram Oxalate	Escitalopram Oxalate	65	18
Glimepiride	Glimepiride	65	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	21
Jardiance	Empagliflozin	59	23
Potassium Chloride	Potassium Chloride	57	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	16
Flecainide Acetate	Flecainide Acetate	53	13
Irbesartan	Irbesartan	53	16
Mounjaro	Tirzepatide	51	11
Methylprednisolone	Methylprednisolone	50	42
Propranolol Hcl	Propranolol Hcl	50	19
Torsemide	Torsemide	49	14
Cilostazol	Cilostazol	48	13
Finasteride	Finasteride	48	16
Pravastatin Sodium	Pravastatin Sodium	47	14
Repatha Sureclick	Evolocumab	47	12
Pioglitazone Hcl	Pioglitazone Hcl	46	19
Testosterone Cypionate	Testosterone Cypionate	44	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	13
Benazepril Hcl	Benazepril Hcl	42	12
Celecoxib	Celecoxib	42	12
Famotidine	Famotidine	38	13
Ozempic	Semaglutide	37	suppressed
Allopurinol	Allopurinol	36	12
Opsumit	Macitentan	36	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	34	13
Meloxicam	Meloxicam	33	14
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	32	suppressed
Valsartan	Valsartan	31	suppressed
Indapamide	Indapamide	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Propranolol Hcl Er	Propranolol Hcl	30	suppressed
Nebivolol Hcl	Nebivolol Hcl	29	suppressed
Nitroglycerin	Nitroglycerin	29	20
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	27	11
Diclofenac Sodium	Diclofenac Sodium	27	12
Diltiazem 24hr Er	Diltiazem Hcl	27	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	26	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Azithromycin	Azithromycin	23	21
Cholestyramine	Cholestyramine (With Sugar)	23	11
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Prednisone	Prednisone	22	14
Baclofen	Baclofen	21	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	21	suppressed
Metolazone	Metolazone	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	20	suppressed
Dutasteride	Dutasteride	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Eplerenone	Eplerenone	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Estradiol	Estradiol	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Levofloxacin	Levofloxacin	18	12
Alprazolam	Alprazolam	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Guanfacine Hcl	Guanfacine Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Ramipril	Ramipril	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Lactulose	Lactulose	15	suppressed
Nitroglycerin Patch	Nitroglycerin	15	suppressed
Tadalafil	Tadalafil	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Methimazole	Methimazole	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Propafenone Hcl	Propafenone Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error